Article

Shedding Light on the Mystery of Chronic Pain

New breakthroughs in our understanding of the physical and biochemical pathways of pain may soon lead to effect disease-modifying drugs.

New breakthroughs in our understanding of the physical and biochemical pathways of pain may soon lead to effect disease-modifying drugs.

Watch as Elliot Krane, MD, director of Pain Management Services at Lucile Packard Children's Hospital at Stanford, gives a TED Talk on the “mystery of chronic pain.” He shares the story of a patient who fell and sprained her wrist, but presented to his clinic three months later suffering from dystonia and allodynia, with pain “that had spread from her wrist to her hands, to her fingertips, from her wrist up to her elbow, almost all the way to her shoulder.”

Krane discusses neurotransmitters; the role of glial cells “in the modulation, amplification, and in the case of pain, the distortion of sensory experiences;” and the various forms of therapy that can be employed to treat and manage chronic pain.

A complete interactive transcript of this presentation is also provided.

Related Videos
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.